NCT03119623View on ClinicalTrials.gov

Comparing ARNI With ACE Inhibitor on Endothelial Function

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

June 1, 2017

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions

Heart Failure With Reduced Ejection Fraction

Interventions

DRUG

sacubitril/valsartan

Sacubitril/valsartan 100mg titrated up to sacubitril/valsartan 200mg

DRUG

Enalapril

enalapril 5mg, titrated up to 10mg po BID

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Brigham and Women's Hospital

OTHER